Journals / Kafkas Journal of Medical Sciences / 2022 / Cilt: 12 - Sayı: 2

The evaluation of migraine frequency in patients with psoriasis

Pages
160–164
Publication Date
2022-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study presented important outputs that the severity and duration of psoriasis disease might be related to migraine disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Psoriasis, previously thought to be a disease restricted to the skin, is now considered systemic, accompanied by numerous comorbidities.
📊
Key Findings & Data:A total of 80 people, including 40 patients over the age of 18 who applied to the outpatient clinic and were diagnosed with psoriasis, and 40 people with similar gender and age characteristics and other skin problems, were included in the control group.
💡
Conclusion & Impact:Conclusion: Our study presented important outputs that the severity and duration of psoriasis disease might be related to migraine disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:psoriasis · inflammation · vascular

Abstract

Aim: Psoriasis, previously thought to be a disease restricted to the skin, is now considered systemic, accompanied by numerous comorbidities. Our study aimed to establish the migraine frequency in psoriasis patients and assess the relationship between the severity and duration of psoriasis and the frequency and severity of migraine. Materials and Methods: This case-control study was performed in the dermatology outpatient clinic. A total of 80 people, including 40 patients over the age of 18 who applied to the outpatient clinic and were diagnosed with psoriasis, and 40 people with similar gender and age characteristics and other skin problems, were included in the control group. Results: The frequency of migraine in psoriasis patients was 35.0% and 15.0% in the control group. In psoriasis patients, the median Psoriasis Area and Severity Index (PASI) score was 3.60 (1.20-13.20) in patients without migraine and 2.90 (1.20-12.00) in patients with migraine. Migraine frequency was 45.0% in patients suffering from the disease for more than eight years and 25.0% in patients suffering for eight years or less. The incidence of migraine was significantly higher in patients who had psoriasis for more than eight years than in the control group. Conclusion: Our study presented important outputs that the severity and duration of psoriasis disease might be related to migraine disease.

🔖

Cite This Article

SARAÇ, G. A., NAYIR, T., ŞİRİN, H., KETREZ, G., GÜMÜŞYAYLA, Ş., TANACAN, E., ROTA, D. D. (2022). The evaluation of migraine frequency in patients with psoriasis. Kafkas Journal of Medical Sciences, Cilt: 12 - Sayı: 2, 160–164. https://ajindex.com/articles/891931

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Atakan N, Doğan S. Psoriazis Sistemik Bir Hastalık mıdır? Turk J Dermatol. 2012;6:119-122.
  2. Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017;76(3):377-390.
  3. Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011;165(5):1037-1043.
  4. Kim WB, Jerome D, Frcpc M, Yeung J. Clinical Review Diagnosis and management of psoriasis. Can Fam Physician. 2017;63:278-285. www.cfp.ca 5. Hu SC, Lan CE. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. Int J Mol Sci. 2017;18(10).
  5. Amanat M, Salehi M, Rezaei N. Neurological and psychiatric disorders in psoriasis. Rev Neurosci. 2018;29(7):805-813.
  6. Boehncke WH, Schön MP. Psoriasis. Lancet (London, England). 2015;386(9997):983-994.
  7. Akburak Ö. Dicle Üniversitesi Dermatoloji Polikliniğine Başvuran Psoriazis Tanılı Hastalarda Migren Görülme Sıklığının Araştırılması. Dicle Üniversitesi. 2018
  8. MacGregor E A. Migraine. Ann Intern Med. 2017;166(7):ITC49-ITC64.
  9. Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631-649.
  10. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006;46(2):200-207.
  11. Capo A, Affaitati G, Giamberardino MA, Amerio P. Psoriasis and migraine. J Eur Acad Dermatology Venereol. 2018;32(1):57-61.
  12. Bonifati C, Berardesca E. Clinical outcome measures of psoriasis. Reumatismo. 2007;59 Suppl 1(SUPPL. 1):64-67.
  13. Bilaç C, Şahin MT, Öztürkcan S. Dermatolojide hastalık şiddeti skorlama sistemleri. Turkderm-Arch Turk Dermatol Venerol. 2016;50:42-53.
  14. Topal İO, Değirmentepe E, Cüre K, Kızıltaç U, Hökenek NB, Kocatürk E. Psoriasisl